Pharmabiz

Thryv Therapeutics begins patient enrollment in Wave II study for Long QT Syndrome; receives US FDA fast track designation for THRV-1268

Thryv Therapeutics begins patient enrollment in Wave II study for Long QT Syndrome; receives US FDA fast track designation for THRV-1268: San Francisco ...
Pharmabiz

Philip Morris International expands its partnership with Ducati Corse as decades-long partnership races forward with purpose

Philip Morris International expands its partnership with Ducati Corse as decades-long partnership races forward with purpose: Stamford, Connecticut Saturday, April 25, 2026, 17:00 ...
Pharmabiz

Worldwide Clinical Trials, Medidata partner to embed Medidata AI across the full clinical trial lifecycle; bolsters study execution and delivery excellence

Worldwide Clinical Trials, Medidata partner to embed Medidata AI across the full clinical trial lifecycle; bolsters study execution and delivery excellence: Research Triangle Park ...
Pharmabiz

WHO reports measurable health impact in 2025 amid transition to new strategy

WHO reports measurable health impact in 2025 amid transition to new strategy: Geneva Saturday, April 25, 2026, 15:00 Hrs [IST] The World Health Organization (WHO) released its Res ...
Pharmabiz

Addex spin-out company Neurosterix on track to complete phase 1 study of NTX-253 for schizophrenia in Q2 2026

Addex spin-out company Neurosterix on track to complete phase 1 study of NTX-253 for schizophrenia in Q2 2026: Geneva, Switzerland Saturday, April 25, 2026, 14:00 Hrs [IST] Addex ...